References
- Unwin N, Shaw J, Zimmet P, et al. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med. 2002; 19(9):708-23.
- American Diabetes Association. Standards of Medical Care in Diabetes – 2017. Diabetes Care. 2017; 40 (Suppl. 1):S1-S135.
- Hanefeld M, Koehler C, Fuecker K, et al. Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study. Diabetes Care. 2003; 26(3):868-74.
- Meyer C, Pimenta W, Woerle HJ, et al. Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans. Diabetes Care. 2006; 29(8):1909-14.
- McMaster University Evidence Based Practice Center. Diagnosis, prognosis and treatment of impaired glucose tolerance and impaired fasting glucose. Evidence Report 128. 2005.
- Chakarova N. Cardiovascular risk in prediabetic conditions – impaired fasting glucose and impaired glucose tolerance [in Bulgarian] Dissertation, 2011, Sofia.
- World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of a WHO/IDF consultation. Geneva, WHO, 2006.
- Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018; 39: 3021-3104.
- Festa A, D’Agostino R Jr, Hanley AJ, et al. Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose. Diabetes. 2004; 53(6):1549-55.
- Nabila S, Kim JE, Choi J, et al. Associations Between Modifiable Risk Factors and Changes in Glycemic Status Among Individuals With Prediabetes. Diabetes Care. 2023; 46(3):535-543. doi: 10.2337/dc22-1042.
- Li Z, Kang S, Kang H. Development and validation of nomograms for predicting cardiovascular disease risk in patients with prediabetes and diabetes. Sci Rep. 2024; 14(1):20909. doi: 10.1038/s41598-024-71904-3.
- Ishikawa J, Schwartz JE, Pickering TG. Pre-diabetes is Associated with Masked Hypertension. Circulation. 2009; 120:S1060.
- Geijerstam PA, Engvall J, Östgren CJ, et al. Home Blood Pressure Compared with Onjce Blood Pressure in Relation to Dysglycemia. Am J Hypertens. 2022; 35(9):810-819.
- Kotsis V, Stabouli S, Toumanidis S, et al. Target organ damage in „white coat hypertension“ and „masked hypertension“. Am J Hypertens 2008; 21: 393-399.
- Hänninen MR, Niiranen TJ, Puukka PJ, et al. Determinants of masked hypertension in the general population: the Finn-Home study. J Hypertens 2011; 10: 1880-1888.
- Gupta AK, Greenway FL, Cornelissen G, et al. Prediabetes is associated with abnormal circadian blood pressure variability. J Hum Hypertens. 2008; 22(9):627-33.
- Jug J, Delalić Ð, Bralić Lang V, et al. Prediabetes, Non-Dipping Profile and Hypertension-A Recipe for Increased Arterial Stiffness. Biomedicines. 2023; 11(4):1065. doi: 10.3390/biomedicines11041065.
- Obayashi K, Saeki K, Kurumatani N. Nighttime BP in Elderly Individuals with Prediabetes/Diabetes with and without CKD: The HEIJO-KYO Study. Clin J Am Soc Nephrol. 2016; 11(5):867-74.
- Kwon BJ, Kim DW, Park MW, et al. Clinical implications of combined glucose intolerance in treatment-naïve hypertensive patients. Clin Exp Hypertens. 2018; 40(8):762-771.